Skip to main content

The European Journal of Health Economics

Ausgabe 3/2025

Inhalt (12 Artikel)

Psychometric validation of the Chinese versions of EQ-5D-Y-3L and the experimental EQ-TIPS in children and adolescents with COVID-19

  • Open Access
  • Original Paper

Wenjing Zhou, Yaqin Li, Jan Busschbach, Michael Herdman, Zhihao Yang, Yanming Lu

The formal care costs of dementia: a longitudinal study using Swedish register data

  • Open Access
  • Original Paper

Jennifer Zilling, Ulf-G. Gerdtham, Johan Jarl, Sanjib Saha, Sofie Persson

A critical review of the use of R2 in risk equalization research

  • Open Access
  • Original Paper

Wynand P. M. M. van de Ven, Richard C. van Kleef

Testing four cognition bolt-on items to the EQ-5D in a general Chinese population

  • Original Paper

Meixia Liao, Hongyan Wu, Zhihao Yang, Yan Huang, Mathieu F. Janssen, Gouke Bonsel, Nan Luo

Cost-effectiveness of hydroxychloroquine retinopathy screening: the current guideline versus no screening and reduced regimens

  • Open Access
  • Original Paper

Sara W. Quist, Sophie te Dorsthorst, Roel D. Freriks, Maarten J. Postma, Carel B. Hoyng, Freekje van Asten

Cost effectiveness of a GP delivered medication review to reduce polypharmacy and potentially inappropriate prescribing in older patients with multimorbidity in Irish primary care: the SPPiRE cluster randomised controlled trial

  • Open Access
  • Original Paper

Paddy Gillespie, Frank Moriarty, Susan M. Smith, Anna Hobbins, Sharon Walsh, Barbara Clyne, Fiona Boland, Tara McEnteggart, Michelle Flood, Emma Wallace, Caroline McCarthy

Trends in NICE technology appraisals of non-small cell lung cancer drugs over the last decade

  • Open Access
  • Original Paper

Lotte Westerink, Sharon Wolters, Guiling Zhou, Arjan Postma, Cornelis Boersma, Job Frank Martien van Boven, Maarten Jacobus Postma

The added value of the cognition, dining, gastrointestinal problems, sleep and tiredness bolt-on dimensions to the EQ-5D-5L in patients with coeliac disease

  • Open Access
  • Original Paper

M. Mercédesz Angyal, Mathieu F. Janssen, Péter L. Lakatos, Valentin Brodszky, Fanni Rencz

Valuation of the EQ-5D-3L in Jordan

  • Open Access
  • Original Paper

Abeer Al Rabayah, Bram Roudijk, Fredrick Dermawan Purba, Fanni Rencz, Saad Jaddoua, Uwe Siebert

Should Scotland provide genome-wide sequencing for the diagnosis of rare developmental disorders? A cost-effectiveness analysis

  • Open Access
  • Original Paper

Michael Abbott, Mandy Ryan, Rodolfo Hernández, Lynda McKenzie, Sebastian Heidenreich, Lynne Hocking, Caroline Clark, Morad Ansari, David Moore, Anne Lampe, Ruth McGowan, Jonathan Berg, Zosia Miedzybrodzka

An assessment of the implications of distribution remuneration and taxation policies on the final prices of prescription medicines: evidence from 35 countries

  • Open Access
  • Original Paper

Giovanny Leon, Christophe Carbonel, Aparajit Rampuria, Ravindra Singh Rajpoot, Parth Joshi, Panos Kanavos